Literature DB >> 16215690

Apoptosis in UV-C light irradiated p53 wild-type, apaf-1 and p53 knockout mouse embryonic fibroblasts: interplay of receptor and mitochondrial pathway.

M T Tomicic1, M Christmann, B Kaina.   

Abstract

Mouse embryonic fibroblasts (MEFs) deficient for the transcription factor p53 are hypersensitive to UV-C light. They also show a reduced recovery from UV-C induced replication blockage and are unable to repair UV-C photoproducts. In this study, we utilized wild-type (wt), Apaf-1 deficient (apaf-1(-/-)) and p53 deficient (p53(-/-)) MEFs in order to elucidate the role of non-repaired UV-C lesions in apoptotic signalling. Corresponding with the cellular sensitivity determined by the WST assay, p53(-/-) cells displayed the highest level of apoptosis, whereas wt cells showed moderate apoptosis after UV-C irradiation. Apaf1(-/-) cells were most resistant. In wt cells apoptosis was executed both via the mitochondrial and the receptor-mediated pathway, as shown by Bcl-2 decline, induction of fasR and activation of caspases-3,8,9. In apaf-1(-/-) (p53(+/+)) cells, the mitochondrial pathway was blocked downstream of Bcl-2, indicating that in this case apoptosis was mediated via the induction of fasR and caspase-3,8 activation. In p53 deficient cells, non-repaired UV-C induced DNA lesions triggered sustained up-regulation of fas ligand (fasL) mRNA, which was not seen in wt and apaf-1(-/-) cells. Therefore, in p53(-/-) MEFs, the receptor/ligand triggered pathway appeared to be dominant. This was confirmed by significant reduction of apoptosis after DN-FADD transfection. As opposed to wt and apaf-1(-/-) cells, p53 deficient MEFs showed no induction of Fas receptor and no Bcl-2 decline. Nevertheless, the resulting caspase-8 and -3 activation was stronger compared to wt and apaf-1(-/-) cells. The data indicate that UV-C light activates in MEFs both the Fas (CD95, Apo-1) receptor and the mitochondrial damage pathways. In p53(-/-) cells, however, the high level of non-repaired DNA damage forces signalling by fasL upregulation, leading to enhanced UV-C-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16215690     DOI: 10.1007/s10495-005-1392-3

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  6 in total

1.  The LIM Protein Zyxin Binds CARP-1 and Promotes Apoptosis.

Authors:  Martial Hervy; Laura M Hoffman; Christopher C Jensen; Mark Smith; Mary C Beckerle
Journal:  Genes Cancer       Date:  2010-05-01

2.  Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex.

Authors:  Hacer Guvenc; Marat S Pavlyukov; Kaushal Joshi; Habibe Kurt; Yeshavanth K Banasavadi-Siddegowda; Ping Mao; Christopher Hong; Ryosuke Yamada; Chang-Hyuk Kwon; Deepak Bhasin; Somsundaram Chettiar; Gaspar Kitange; In-Hee Park; Jann N Sarkaria; Chenglong Li; Mihail I Shakhparonov; Ichiro Nakano
Journal:  Clin Cancer Res       Date:  2012-12-18       Impact factor: 12.531

3.  Effect of retinoic acid on apoptosis and expression of Fas proteins in mouse blastocysts cultured in vitro.

Authors:  Yan'e Xiong; Duanlian Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

4.  Three prime exonuclease I (TREX1) is Fos/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced DNA damage.

Authors:  Markus Christmann; Maja T Tomicic; Dorthe Aasland; Nicole Berdelle; Bernd Kaina
Journal:  Nucleic Acids Res       Date:  2010-05-28       Impact factor: 16.971

Review 5.  Mechanisms of apoptosis in Crustacea: What conditions induce versus suppress cell death?

Authors:  Michael A Menze; Grady Fortner; Suman Nag; Steven C Hand
Journal:  Apoptosis       Date:  2010-03       Impact factor: 4.677

6.  The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancer.

Authors:  Masato Hori; Tomoharu Miki; Mayumi Okamoto; Futoshi Yazama; Hiroaki Konishi; Hiroshi Kaneko; Fumio Shimamoto; Takahide Ota; Achim Temme; Masaaki Tatsuka
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.